+987.9%
MRNA vs NIO
-54.1%
+1,042.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.4% | +9.7% | +11.8% |
| 7D | +20.6% | -0.6% | +21.2% | +21.0% |
| 30D | +27.1% | -3.5% | +30.7% | +29.1% |
| 3M | +353.4% | -30.7% | +384.1% | +407.7% |
| 6M | +446.3% | -45.6% | +491.9% | +531.5% |
| YTD | +776.2% | -35.3% | +811.5% | +873.6% |
| 1Y | +987.9% | -53.9% | +1,041.8% | +1,479.3% |
| All | +987.9% | -54.1% | +1,042.0% | +1,479.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NIO.
Daily Out/Under-Performance
Portfolio return minus NIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling